About Rosanne Reitsema
Rosanne Reitsema is a postdoctoral researcher at the School of Medical Sciences, Örebro University, Sweden. Rosanne obtained her BSc degree in Biology and MSc degree in Biomedical Sciences at the University of Groningen, the Netherlands. She did her PhD in the Vasculitis Expertise Center at the University Medical Center in Groningen. In March 2022, Rosanne defended her PhD thesis with the title: “T cells in healthy ageing and age-associated vasculitides”.
The Knowledge Foundation awarded a two-year postdoc fellowship to Rosanne to study immune responses in atherosclerosis. She now studies the effects of blocking IL-17 and HMGB1 on immune responses in atherosclerosis patients, in close collaboration with Affibody and TATAA Biocenter.
Articles in journals
- Reitsema, R. D. , Hesselink, B. , Abdulahad, W. H. , van der Geest, K. S. M. , Brouwer, E. , Heeringa, P. & van Sleen, Y. (2023). Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica. Frontiers in Immunology, 14.
- van Nieuwland, M. , Esen, I. , Reitsema, R. D. , Abdulahad, W. H. , van Sleen, Y. , Jiemy, W. F. , Sandovici, M. , Brouwer, E. & et al. (2023). Evidence for increased interferon type I activity in CD8+ T cells in giant cell arteritis patients. Frontiers in Immunology, 14.
- Kurt, S. , Pirronello, F. , Reitsema, R. , Demirel, I. , Rangel, I. , Sirsjö, A. , Dreifaldt, M. & Kumawat, A. (2023). Increased proportion of circulating neutrophils with impaired phagocytosis capacity in patients with peripheral arterial disease. In: Atherosclerosis. Paper presented at 91st Annual Meeting of the European-Atherosclerosis-Society (EAS 2023), Mannheim, Germany, May 21-24, 2023. (pp. S22-S22). Elsevier.
- Pirronello, F. , Kurt, S. , Reitsema, R. , Rangel, I. , Dreifaldt, M. , Sirsjö, A. & Kumawat, A. (2023). Phenotypic and functional characterization of T cell immune responses in peripheral arterial disease. In: Atherosclerosis. Paper presented at 91st Annual Meeting of the European-Atherosclerosis-Society (EAS 2023), Mannheim, Germany, May 21-24, 2023. (pp. S25-S25). Elsevier.